// startup autopsy

Repromedix

Diagnosing male infertility in a market that wasn't ready

marketfitSilent Shutdown

Quiet closure with no public announcement · Fatal mistake: Underestimated the complexity of insurance reimbursement and clinical workflow integration required to achieve sustainable commercial adoption.

Founded	2010
Closed	2016
Country	USA
Sector	Healthtech

50%

Key Events Timeline

2010-03

FOUNDING

Repromedix founded to commercialize advanced male reproductive health diagnostics for fertility clinics.

2012-08

PRODUCT LAUNCH

Launched proprietary diagnostic testing panels targeting fertility specialists, receiving limited but enthusiastic early clinical uptake.

2014-05

FUNDING

Secured funding to expand commercial operations and pursue insurance reimbursement approvals for its diagnostic tests.

2016-06

SHUTDOWN

Repromedix ceased operations after failing to achieve sufficient clinical adoption and reimbursement coverage to sustain the business.

Full Analysis

Analyst plan

Documented cause

Repromedix developed diagnostic testing services for male reproductive health, targeting fertility clinics. The company faced structural challenges in a niche market with inherently slow adoption cycles. Fertil...

ity clinics were reluctant to replace established testing protocols, creating a significant barrier to customer acquisition. Insurance reimbursement presented another critical obstacle, limiting clini

Verified lesson

“...”

Unlock full lesson →

HypeCycle · MoatType · ResearchTags

Repromedix collapsed from underestimated the complexity of insurance reimbursement and clinical workflow integration required to achieve sustainable commercial adoption.. Documented cause, verified lesson, all failure signals.

Unlock full analysis →Create free account

See all plans·Analyst plan — €149/mo

Key Events Timeline

Documented cause

Verified lesson

Similar patterns